Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment
Most patients with MMN in Japan received induction and maintenance immunoglobulin therapies, which appear to suppress long-term disease progression.
Authors
- Kazumoto Shibuya (ORCID: https://orcid.org/0000-0003-4061-0412)
- Satoshi Kuwabara (ORCID: https://orcid.org/0000-0002-4716-8578)
- Yasunori Sato (ORCID: https://orcid.org/0000-0002-7189-5126)
- Kengo Nagashima (ORCID: https://orcid.org/0000-0003-4529-9045)
- Nagato Kuriyama (ORCID: https://orcid.org/0000-0002-6859-535X)
- Marie Morooka
- Yuya Aotsuka (ORCID: https://orcid.org/0000-0003-4232-2772)
- Ryo Otani (ORCID: https://orcid.org/0000-0003-4282-1475)
- Tomoki Suichi (ORCID: https://orcid.org/0000-0002-9575-9444)
- Moeko Ogushi
- Hiroki Kano
- Keigo Nakamura (ORCID: https://orcid.org/0000-0003-2570-9529)
- Sonoko Misawa (ORCID: https://orcid.org/0000-0002-8533-5664)
Institutions
- Chiba University (JP)
- Keio University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Keio University Hospital (JP)
Publication Details
- Journal
- Muscle & Nerve
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1002/mus.28251
- Citations
- 5
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.85